Clinical trial · Interventional
Efficacy Study of a Low Volume of Water Intake and Mosapride for Endoscopy in Patients With Subtotal Gastrectomy
Efficacy of a Low Volume of Water Intake and Mosapride for Endoscopy Preparation in Gastric Cancer Patients With Subtotal Gastrectomy: A Randomized Controlled Trial
NCT01284764CI-TRIAL-00005591SMWcompletedPhase 3ClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
A low volume of water intake and mosapride will effectively reduce food residue in remnant stomach for patients who had undergone subtotal gastrectomy due to gastric cancer.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Foreign Body Left During Endoscopic Examination | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Mosapride | Drug | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- NO_INTERVENTION
- label
- midnight fasting
- description
- The patients in this group will have midnight fasting the day before endoscopic examination
- type
- ACTIVE_COMPARATOR
- label
- Mosapride, low volume of water
- description
- The patients in this group will take mosapride and a 500mL water at evening of the day before endoscopic examination.
- interventionNames
- Drug: Mosapride
Primary outcomes (1)
- measure
- Degrees of food residue using endoscopic scoring system
- timeFrame
- six months
- description
- We plan to evaluate how much a low volume of water and mosapride, compared with routine fasting, reduse food residue in gastric remnant for endoscopy.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 80 Years
Show eligibility criteria text
Inclusion Criteria: * Outpatients who had subtotal gastrectomy for gastric cancer Exclusion Criteria: * Pregnancy * Lactation * History of anastomotic stricture * Recurrent advanced gastric cancer * Poor general condition( \> 2 ECOG) * Other disseminated malignancy * Significant renal failure or congestive heart failure (CHF) * Liver failure
References
Publications (0)
Data not yet available
No reference posted for this study.